Anu Vasudevan

Anu Vasudevan serves as the Director of Analytical Development at NEUVOGEN, Inc. since June 2025, bringing extensive experience in analytical development from previous roles at CARGO Therapeutics and ArsenalBio. At CARGO Therapeutics, Anu held the positions of Associate Director and Principal Scientist, focusing on advanced analytical methods. During tenure at ArsenalBio, leadership was provided to the Cell-Based Assays Group, directing functional assay development for CAR-T products. Prior experience includes significant contributions to the development of analytical methods for COVID-19 and pneumococcal vaccines at Vir Biotechnology and Vaxcyte, respectively. Earlier career milestones include work as an ORISE Fellow at the FDA, where monoclonal antibodies and vaccine potency evaluations were conducted, and a foundational role as a Technical Research Assistant at Brigham and Women's Hospital. Anu holds a Master of Science in Molecular Microbiology and Immunology from The Johns Hopkins University and a Bachelor of Arts in Biological Sciences from Wellesley College.